BUZZ-Artelo Biosciences计划在英国开展青光眼药物研究，股价大涨

路透中文

Mar 18

BUZZ-<a href="https://laohu8.com/S/ARTL">Artelo Biosciences</a>计划在英国开展青光眼药物研究，股价大涨

3月18日 - ** 生物技术公司Artelo Biosciences ARTL.O 股价盘前上涨55%至7.35美元

** 该公司称将测试实验性大麻素药物ART27.13对青光眼的治疗效果，青光眼是一种通过升高眼压损害视力的眼病。

** 称将在英国开展研究，以了解这种口服胶囊能否安全地降低青光眼或眼压过高症患者的眼压。

** 试验由英国青光眼协会（Glaucoma UK）和 HSC 研发公司资助；该公司表示，将于 2026 年第二季度开始招募患者。

** 公司表示，该药物旨在脑外发挥作用，以避免 "亢奋 "或精神改变效应

** 公司称，ART27.13 还在进行对癌症相关体重减轻的测试；青光眼研究可能会扩大其用途 - ARTL

** 2025 年股价下跌 ~81%

(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2620258914"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2620258914\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2620258914?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-03-18 19:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2620258914","market":"hk","top_or_hot":-1,"title":"BUZZ-Artelo Biosciences计划在英国开展青光眼药物研究，股价大涨","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/ARTL\">Artelo Biosciences</a>计划在英国开展青光眼药物研究，股价大涨</title></head><body><p><span>3月18日</span><span> - </span>** <a href=\"https://laohu8.com/S/000504\">生物</a>技术公司<a href=\"https://laohu8.com/S/ATLEW\">Artelo Biosciences</a> <span>ARTL.O</span> 股价盘前上涨55%至7.35美元</p><p>** 该公司称将测试实验性大麻素药物ART27.13对青光眼的治疗效果，青光眼是一种通过升高眼压损害视力的眼病。</p><p>** 称将在英国开展研究，以了解这种口服胶囊能否安全地降低青光眼或眼压过高症患者的眼压。</p><p>** 试验由英国青光眼协会（Glaucoma UK）和 HSC 研发公司资助；该公司表示，将于 2026 年第二季度开始招募患者。</p><p>** 公司表示，该药物旨在脑外发挥作用，以避免 \"亢奋 \"或精神改变效应</p><p>** 公司称，ART27.13 还在进行对癌症相关体重减轻的测试；青光眼研究可能会扩大其用途 - ARTL</p><p>** 2025 年股价下跌 ~81%</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Artelo Biosciences计划在英国开展青光眼药物研究，股价大涨</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Artelo Biosciences计划在英国开展青光眼药物研究，股价大涨\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2026-03-18 19:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/ARTL\">Artelo Biosciences</a>计划在英国开展青光眼药物研究，股价大涨</title></head><body><p><span>3月18日</span><span> - </span>** <a href=\"https://laohu8.com/S/000504\">生物</a>技术公司<a href=\"https://laohu8.com/S/ATLEW\">Artelo Biosciences</a> <span>ARTL.O</span> 股价盘前上涨55%至7.35美元</p><p>** 该公司称将测试实验性大麻素药物ART27.13对青光眼的治疗效果，青光眼是一种通过升高眼压损害视力的眼病。</p><p>** 称将在英国开展研究，以了解这种口服胶囊能否安全地降低青光眼或眼压过高症患者的眼压。</p><p>** 试验由英国青光眼协会（Glaucoma UK）和 HSC 研发公司资助；该公司表示，将于 2026 年第二季度开始招募患者。</p><p>** 公司表示，该药物旨在脑外发挥作用，以避免 \"亢奋 \"或精神改变效应</p><p>** 公司称，ART27.13 还在进行对癌症相关体重减轻的测试；青光眼研究可能会扩大其用途 - ARTL</p><p>** 2025 年股价下跌 ~81%</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nL4S4060ZP:1","article_id":"2620258914","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2620258914","pubTimestamp":1773834566,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Artelo Biosciences计划在英国开展青光眼药物研究，股价大涨3月18日 - ** 生物技术公司Artelo Biosciences ARTL.O 股价盘前上涨55%至7.35美元** 该公司称将测试实验性大麻素药物ART27.13对青光眼的治疗效果，青光眼是一种通过升高眼压损害视力的眼病。** 称将在英国开展研究，以了解这种口服胶囊能否安全地降低青光眼或眼压过高症患者的眼压。** 试验由英国青光眼协会和 HSC 研发公司资助；该公司表示，将于 2026 年第二季度开始招募患者。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4007":"制药","ARTL":"Artelo Biosciences, Inc."},"translate_title":"BUZZ-Artelo Biosciences jumps as it plans glaucoma drug research in the UK","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ARTL":0.9},"content_text":"BUZZ-<a href=\"https://laohu8.com/S/ARTL\">Artelo Biosciences</a>计划在英国开展青光眼药物研究，股价大涨3月18日 - ** 生物技术公司Artelo Biosciences ARTL.O 股价盘前上涨55%至7.35美元** 该公司称将测试实验性大麻素药物ART27.13对青光眼的治疗效果，青光眼是一种通过升高眼压损害视力的眼病。** 称将在英国开展研究，以了解这种口服胶囊能否安全地降低青光眼或眼压过高症患者的眼压。** 试验由英国青光眼协会（Glaucoma UK）和 HSC 研发公司资助；该公司表示，将于 2026 年第二季度开始招募患者。** 公司表示，该药物旨在脑外发挥作用，以避免 \"亢奋 \"或精神改变效应** 公司称，ART27.13 还在进行对癌症相关体重减轻的测试；青光眼研究可能会扩大其用途 - ARTL** 2025 年股价下跌 ~81%(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}